Effect of Vitamin D Supplementation on Severity of Stress Urinary Incontinence in Premenopausal Women With Vitamin D Insufficiency
1 other identifier
interventional
86
1 country
1
Brief Summary
The rationale for conducting the study is based on the fact that stress urinary incontinenc is a prevalent condition among middle age or older women and Vitamin D deficiency may have clinical effects on the pelvic floor muscles and bladder function. Therefore, the study aims to explore the potential link between vitamin D levels and SUI in women in our local population.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2024
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
February 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2024
CompletedFirst Submitted
Initial submission to the registry
November 1, 2024
CompletedFirst Posted
Study publicly available on registry
November 14, 2024
CompletedNovember 14, 2024
November 1, 2024
8 months
November 1, 2024
November 7, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
to see the effect of vitamin supplementation on severity of urinary incontinence
Scoring of the stress urinary incontinence was done based on the International Consultation on Incontinence Questionnaire - Urinary Incontinence Short Form Questionnaire. Severity of SUI was based on these scores, 1-5 (mild), 6-12 (moderate), 13-18 (severe), 19-21 (very severe).
0,4,8 and 12 weeks of treatment
Secondary Outcomes (1)
Impact on qulaity of life
0,4,8 and 12 weeks of treatment
Study Arms (2)
Vitamin D group
ACTIVE COMPARATORGroup A participants received vitamin D supplements orally for 8 weeks along with pelvic floor exercises
Placebo group
PLACEBO COMPARATORGroup B participants received ispaghula husk tablets for 8 weeks along with pelvic floor exercises
Interventions
Vitamin D supplements is thought to reduce the severity of urinary incontinence.Vitamin D supplements were given to Group A
Eligibility Criteria
You may qualify if:
- Women age between 40-49 years
- Women with SUI
You may not qualify if:
- Using hormonal medications (estrogen supplementation)
- Undergoing urogenital-related surgery (incontinence and prolapse surgery)
- Diabetes Mellitus
- Participants with any disorder that interferes with vitamin D absorption, such as inflammatory bowel disease, intestinal bypass surgery, or chronic liver or kidney disease
- Neurological disease affecting the urinary system such as multiple sclerosis, degenerative muscle disease, spinal cord injury
- Women with urinary tract infections
- Women taking supplements ( multivitamins or already taking vitamin D supplementation)
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Shalamar Institute of Health Sciences
Lahore, Punjab Province, 40050, Pakistan
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- OTHER
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- second fellowship trainee in urogynaecology
Study Record Dates
First Submitted
November 1, 2024
First Posted
November 14, 2024
Study Start
February 1, 2024
Primary Completion
September 30, 2024
Study Completion
September 30, 2024
Last Updated
November 14, 2024
Record last verified: 2024-11